News
Posted on 8th October 2020

Member Update on Banned Substance, Zilpaterol

Following the statement from GAIN Equine Nutrition on 3 October, British Eventing would like to remind members that it is the rider’s responsibility to ensure that the horses they are riding are competing free from prohibited substances – both at national and international events.

 

It is strongly advised that any horses that may have inadvertently ingested Zilpaterol, or any other banned substance, are withdrawn from competition. 

A link to the BEFAR pages of the BEF website can be found here: https://www.britishequestrian.org.uk/equine/equine-anti-doping and the FEI clean sport pages for international competitors here - https://inside.fei.org/fei/cleansport/horses

FEI Statement

The FEI would like to inform the equestrian community about a feedstuff contamination with Zilpaterol, a Banned Substance on the Equine Prohibited Substances List, following an alert from feed producer GAIN Equine Nutrition advising its equine customers to refrain from feeding their current stock of GAIN Equine products.

On 2 October 2020, the French horse racing authority France Galop announced that five horses had tested positive to Zilpaterol. The substance appears to have derived from the ingestion of contaminated feed.

Zilpaterol is a beta-agonist drug used as a feed additive to increase muscle mass in beef cattle. It can also improve lung function. A number of countries prohibit its use in food producing animals.

The FEI recommends that samples are kept of batches of feed and supplements given to competition horses to enable a thorough investigation to take place should the horse test positive for Zilpaterol.

Under the FEI Regulations, it is not possible for horses to be tested for Zilpaterol under the Elective Testing scheme as it is a Banned Substance. 
It is strongly advised that horses that may have inadvertently ingested Zilpaterol are withdrawn from competition.

Further information on contamination prevention can be found here

The latest updates from GAIN on this issue are available here.